nodes	percent_of_prediction	percent_of_DWPC	metapath
Porfimer—LDLR—atherosclerosis	0.755	1	CbGaD
Porfimer—LDLR—tunica intima—atherosclerosis	0.0254	0.429	CbGeAlD
Porfimer—LDLR—artery—atherosclerosis	0.00871	0.147	CbGeAlD
Porfimer—LDLR—endothelium—atherosclerosis	0.00735	0.124	CbGeAlD
Porfimer—LDLR—blood vessel—atherosclerosis	0.00678	0.114	CbGeAlD
Porfimer—LDLR—connective tissue—atherosclerosis	0.00348	0.0586	CbGeAlD
Porfimer—LDLR—cardiovascular system—atherosclerosis	0.00303	0.051	CbGeAlD
Porfimer—LDLR—adipose tissue—atherosclerosis	0.00267	0.045	CbGeAlD
Porfimer—LDLR—liver—atherosclerosis	0.00187	0.0315	CbGeAlD
Porfimer—LDLR—Oncostatin M Signaling Pathway—VEGFA—atherosclerosis	0.000128	0.000692	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000128	0.00069	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000128	0.00069	CbGpPWpGaD
Porfimer—LDLR—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000128	0.000689	CbGpPWpGaD
Porfimer—FCGR1A—Class I MHC mediated antigen processing & presentation—CYBA—atherosclerosis	0.000128	0.000689	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—STAT3—atherosclerosis	0.000127	0.000685	CbGpPWpGaD
Porfimer—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—MAPK3—atherosclerosis	0.000126	0.00068	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000126	0.000677	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000123	0.000665	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—MAPK3—atherosclerosis	0.000121	0.000654	CbGpPWpGaD
Porfimer—LDLR—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000119	0.000641	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000114	0.000615	CbGpPWpGaD
Porfimer—LDLR—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000111	0.000598	CbGpPWpGaD
Porfimer—LDLR—Folate Metabolism—TNF—atherosclerosis	0.000109	0.000586	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000108	0.000583	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000108	0.000583	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000108	0.000583	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000108	0.000583	CbGpPWpGaD
Porfimer—LDLR—Vitamin B12 Metabolism—IL6—atherosclerosis	0.000108	0.000581	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000107	0.000576	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000103	0.000556	CbGpPWpGaD
Porfimer—FCGR1A—Class I MHC mediated antigen processing & presentation—SOCS3—atherosclerosis	0.000101	0.000543	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—FCGR3A—atherosclerosis	0.0001	0.000539	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	9.9e-05	0.000533	CbGpPWpGaD
Porfimer—FCGR1A—Interferon Signaling—ICAM1—atherosclerosis	9.73e-05	0.000524	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—FCGR3A—atherosclerosis	9.61e-05	0.000518	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—VCAM1—atherosclerosis	9.54e-05	0.000514	CbGpPWpGaD
Porfimer—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK3—atherosclerosis	9.53e-05	0.000513	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	9.52e-05	0.000513	CbGpPWpGaD
Porfimer—LDLR—Metabolism—LDLRAP1—atherosclerosis	9.41e-05	0.000507	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—NFKB1—atherosclerosis	9.36e-05	0.000504	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—SOCS3—atherosclerosis	9.26e-05	0.000499	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	9.2e-05	0.000496	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—MAPK8—atherosclerosis	9.2e-05	0.000495	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PLTP—atherosclerosis	8.85e-05	0.000477	CbGpPWpGaD
Porfimer—LDLR—Folate Metabolism—IL6—atherosclerosis	8.77e-05	0.000473	CbGpPWpGaD
Porfimer—LDLR—Selenium Micronutrient Network—TNF—atherosclerosis	8.64e-05	0.000465	CbGpPWpGaD
Porfimer—FCGR1A—Class I MHC mediated antigen processing & presentation—CD36—atherosclerosis	8.53e-05	0.00046	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—IL18—atherosclerosis	8.44e-05	0.000455	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	8.2e-05	0.000442	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—AKT1—atherosclerosis	8.19e-05	0.000441	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	8.15e-05	0.000439	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	7.91e-05	0.000426	CbGpPWpGaD
Porfimer—LDLR—SREBP signalling—AKT1—atherosclerosis	7.81e-05	0.000421	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—TGFB1—atherosclerosis	7.79e-05	0.00042	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ABCG8—atherosclerosis	7.67e-05	0.000413	CbGpPWpGaD
Porfimer—LDLR—Metabolism—LTA4H—atherosclerosis	7.67e-05	0.000413	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	7.58e-05	0.000408	CbGpPWpGaD
Porfimer—FCGR1A—Interferon Signaling—IFNG—atherosclerosis	7.4e-05	0.000399	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	7.15e-05	0.000385	CbGpPWpGaD
Porfimer—LDLR—Selenium Micronutrient Network—IL6—atherosclerosis	6.97e-05	0.000375	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—NCF1—atherosclerosis	6.73e-05	0.000363	CbGpPWpGaD
Porfimer—LDLR—Disease—APOA4—atherosclerosis	6.68e-05	0.00036	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CCR2—atherosclerosis	6.62e-05	0.000357	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—ICAM1—atherosclerosis	6.5e-05	0.00035	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.38e-05	0.000344	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CYBA—atherosclerosis	6.33e-05	0.000341	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—TLR2—atherosclerosis	6.15e-05	0.000331	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ABCG1—atherosclerosis	6.07e-05	0.000327	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HRH1—atherosclerosis	5.96e-05	0.000321	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CD40—atherosclerosis	5.91e-05	0.000318	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—FCGR3A—atherosclerosis	5.83e-05	0.000314	CbGpPWpGaD
Porfimer—LDLR—Disease—APOA2—atherosclerosis	5.75e-05	0.00031	CbGpPWpGaD
Porfimer—LDLR—Metabolism—FABP4—atherosclerosis	5.7e-05	0.000307	CbGpPWpGaD
Porfimer—LDLR—Metabolism—LCAT—atherosclerosis	5.7e-05	0.000307	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOA4—atherosclerosis	5.6e-05	0.000302	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CD14—atherosclerosis	5.55e-05	0.000299	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CYP7A1—atherosclerosis	5.5e-05	0.000296	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—AKT1—atherosclerosis	5.42e-05	0.000292	CbGpPWpGaD
Porfimer—LDLR—Disease—BGN—atherosclerosis	5.32e-05	0.000286	CbGpPWpGaD
Porfimer—FCGR1A—Interferon Signaling—MAPK3—atherosclerosis	5.29e-05	0.000285	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.24e-05	0.000282	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—VCAM1—atherosclerosis	5.14e-05	0.000277	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CYP27A1—atherosclerosis	5.08e-05	0.000274	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5e-05	0.00027	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—SOCS3—atherosclerosis	4.99e-05	0.000269	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—IFNG—atherosclerosis	4.94e-05	0.000266	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.88e-05	0.000263	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ALOX15—atherosclerosis	4.82e-05	0.00026	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ALOX5AP—atherosclerosis	4.82e-05	0.00026	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOA2—atherosclerosis	4.82e-05	0.00026	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PLA2G2A—atherosclerosis	4.82e-05	0.00026	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ABCG5—atherosclerosis	4.76e-05	0.000256	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.75e-05	0.000256	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—APOA4—atherosclerosis	4.68e-05	0.000252	CbGpPWpGaD
Porfimer—LDLR—Disease—CST3—atherosclerosis	4.63e-05	0.00025	CbGpPWpGaD
Porfimer—LDLR—Metabolism—LPA—atherosclerosis	4.6e-05	0.000248	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—AGER—atherosclerosis	4.55e-05	0.000245	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CD40LG—atherosclerosis	4.53e-05	0.000244	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—PRKCG—atherosclerosis	4.5e-05	0.000242	CbGpPWpGaD
Porfimer—LDLR—Metabolism—BGN—atherosclerosis	4.45e-05	0.00024	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.42e-05	0.000238	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—IL1B—atherosclerosis	4.41e-05	0.000238	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOA5—atherosclerosis	4.41e-05	0.000237	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CD36—atherosclerosis	4.4e-05	0.000237	CbGpPWpGaD
Porfimer—LDLR—Disease—NAMPT—atherosclerosis	4.39e-05	0.000236	CbGpPWpGaD
Porfimer—LDLR—Disease—APOC3—atherosclerosis	4.33e-05	0.000233	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCL4—atherosclerosis	4.31e-05	0.000232	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.28e-05	0.000231	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PLA2G1B—atherosclerosis	4.24e-05	0.000229	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CD36—atherosclerosis	4.22e-05	0.000228	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.19e-05	0.000226	CbGpPWpGaD
Porfimer—LDLR—Disease—HSPA1B—atherosclerosis	4.16e-05	0.000224	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.16e-05	0.000224	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.15e-05	0.000223	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—NFKB1—atherosclerosis	4.11e-05	0.000222	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ALOX5—atherosclerosis	4.1e-05	0.000221	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—NCF1—atherosclerosis	4.08e-05	0.00022	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—PDGFB—atherosclerosis	4.06e-05	0.000219	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—APOA2—atherosclerosis	4.03e-05	0.000217	CbGpPWpGaD
Porfimer—LDLR—Disease—NCF1—atherosclerosis	4.03e-05	0.000217	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CRP—atherosclerosis	3.96e-05	0.000214	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—PDGFB—atherosclerosis	3.89e-05	0.00021	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CCR2—atherosclerosis	3.85e-05	0.000208	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—UTS2—atherosclerosis	3.84e-05	0.000207	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CYBA—atherosclerosis	3.84e-05	0.000207	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—TLR4—atherosclerosis	3.8e-05	0.000205	CbGpPWpGaD
Porfimer—LDLR—Disease—CYBA—atherosclerosis	3.79e-05	0.000204	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.79e-05	0.000204	CbGpPWpGaD
Porfimer—LDLR—Disease—PARP1—atherosclerosis	3.71e-05	0.0002	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—STAT3—atherosclerosis	3.7e-05	0.000199	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CX3CR1—atherosclerosis	3.68e-05	0.000199	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CASR—atherosclerosis	3.68e-05	0.000199	CbGpPWpGaD
Porfimer—LDLR—Metabolism—NAMPT—atherosclerosis	3.67e-05	0.000198	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.65e-05	0.000197	CbGpPWpGaD
Porfimer—LDLR—Metabolism—LIPC—atherosclerosis	3.65e-05	0.000197	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOC3—atherosclerosis	3.63e-05	0.000196	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CX3CL1—atherosclerosis	3.61e-05	0.000195	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD40—atherosclerosis	3.58e-05	0.000193	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—TLR2—atherosclerosis	3.58e-05	0.000193	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—MAPK3—atherosclerosis	3.53e-05	0.00019	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CETP—atherosclerosis	3.52e-05	0.00019	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—ICAM1—atherosclerosis	3.5e-05	0.000189	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CNR2—atherosclerosis	3.43e-05	0.000185	CbGpPWpGaD
Porfimer—LDLR—Metabolism—SCARB1—atherosclerosis	3.37e-05	0.000182	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.28e-05	0.000177	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD14—atherosclerosis	3.23e-05	0.000174	CbGpPWpGaD
Porfimer—LDLR—Metabolism—HMGCR—atherosclerosis	3.19e-05	0.000172	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—VCAM1—atherosclerosis	3.12e-05	0.000168	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—VWF—atherosclerosis	3.05e-05	0.000165	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—APOC3—atherosclerosis	3.03e-05	0.000163	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—SOCS3—atherosclerosis	3.02e-05	0.000163	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCL3—atherosclerosis	2.95e-05	0.000159	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.87e-05	0.000155	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ABCA1—atherosclerosis	2.84e-05	0.000153	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NCF1—atherosclerosis	2.82e-05	0.000152	CbGpPWpGaD
Porfimer—LDLR—Disease—APOB—atherosclerosis	2.79e-05	0.00015	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL18—atherosclerosis	2.76e-05	0.000149	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD40LG—atherosclerosis	2.75e-05	0.000148	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCR2—atherosclerosis	2.66e-05	0.000144	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—EDNRA—atherosclerosis	2.66e-05	0.000144	CbGpPWpGaD
Porfimer—LDLR—Disease—LPL—atherosclerosis	2.66e-05	0.000143	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CYBA—atherosclerosis	2.65e-05	0.000143	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—AGER—atherosclerosis	2.65e-05	0.000143	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PRKCG—atherosclerosis	2.62e-05	0.000141	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PLAT—atherosclerosis	2.6e-05	0.00014	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—GHRL—atherosclerosis	2.6e-05	0.00014	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PARP1—atherosclerosis	2.6e-05	0.00014	CbGpPWpGaD
Porfimer—LDLR—Disease—PRKCG—atherosclerosis	2.59e-05	0.000139	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—IL6—atherosclerosis	2.58e-05	0.000139	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CD36—atherosclerosis	2.56e-05	0.000138	CbGpPWpGaD
Porfimer—LDLR—Metabolism—HMOX1—atherosclerosis	2.44e-05	0.000131	CbGpPWpGaD
Porfimer—LDLR—Disease—MTHFR—atherosclerosis	2.4e-05	0.000129	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—PDGFB—atherosclerosis	2.36e-05	0.000127	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOB—atherosclerosis	2.33e-05	0.000126	CbGpPWpGaD
Porfimer—LDLR—Disease—PDGFB—atherosclerosis	2.33e-05	0.000126	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CRP—atherosclerosis	2.31e-05	0.000124	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—NFKB1—atherosclerosis	2.31e-05	0.000124	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—KNG1—atherosclerosis	2.28e-05	0.000123	CbGpPWpGaD
Porfimer—LDLR—Metabolism—GSTM1—atherosclerosis	2.27e-05	0.000122	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MAPK8—atherosclerosis	2.27e-05	0.000122	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—AGTR1—atherosclerosis	2.27e-05	0.000122	CbGpPWpGaD
Porfimer—LDLR—Disease—APOE—atherosclerosis	2.23e-05	0.00012	CbGpPWpGaD
Porfimer—LDLR—Metabolism—LPL—atherosclerosis	2.23e-05	0.00012	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—NFKB1—atherosclerosis	2.22e-05	0.000119	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—TLR4—atherosclerosis	2.21e-05	0.000119	CbGpPWpGaD
Porfimer—LDLR—Disease—CAV1—atherosclerosis	2.21e-05	0.000119	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PLG—atherosclerosis	2.21e-05	0.000119	CbGpPWpGaD
Porfimer—LDLR—Disease—APOA1—atherosclerosis	2.2e-05	0.000119	CbGpPWpGaD
Porfimer—LDLR—Metabolism—GPX1—atherosclerosis	2.17e-05	0.000117	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—ICAM1—atherosclerosis	2.12e-05	0.000114	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CD36—atherosclerosis	2.12e-05	0.000114	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SOCS3—atherosclerosis	2.09e-05	0.000113	CbGpPWpGaD
Porfimer—LDLR—Disease—NOS2—atherosclerosis	2.08e-05	0.000112	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MMP3—atherosclerosis	2.02e-05	0.000109	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IGF2—atherosclerosis	2.01e-05	0.000108	CbGpPWpGaD
Porfimer—LDLR—Metabolism—MTHFR—atherosclerosis	2.01e-05	0.000108	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MAPK3—atherosclerosis	1.98e-05	0.000107	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PPARA—atherosclerosis	1.97e-05	0.000106	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—APOB—atherosclerosis	1.95e-05	0.000105	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—EDN1—atherosclerosis	1.92e-05	0.000103	CbGpPWpGaD
Porfimer—LDLR—Metabolism—AGT—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCL5—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Porfimer—LDLR—Disease—INS—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOE—atherosclerosis	1.87e-05	0.000101	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—LPL—atherosclerosis	1.86e-05	0.0001	CbGpPWpGaD
Porfimer—LDLR—Metabolism—CAV1—atherosclerosis	1.85e-05	9.97e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—APOA1—atherosclerosis	1.85e-05	9.95e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PRKCG—atherosclerosis	1.81e-05	9.76e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SPP1—atherosclerosis	1.76e-05	9.51e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—SERPINE1—atherosclerosis	1.75e-05	9.43e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PIK3CG—atherosclerosis	1.69e-05	9.08e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—NOS3—atherosclerosis	1.67e-05	9e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PDGFB—atherosclerosis	1.63e-05	8.8e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PPARG—atherosclerosis	1.63e-05	8.77e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IFNG—atherosclerosis	1.61e-05	8.7e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—INS—atherosclerosis	1.6e-05	8.6e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—AGT—atherosclerosis	1.59e-05	8.59e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—LEP—atherosclerosis	1.56e-05	8.41e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—APOE—atherosclerosis	1.56e-05	8.41e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CAV1—atherosclerosis	1.55e-05	8.34e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—APOA1—atherosclerosis	1.54e-05	8.32e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—PTGS2—atherosclerosis	1.53e-05	8.23e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—ESR1—atherosclerosis	1.49e-05	8.03e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—F2—atherosclerosis	1.47e-05	7.94e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—ALB—atherosclerosis	1.46e-05	7.88e-05	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—IL6—atherosclerosis	1.45e-05	7.8e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL1B—atherosclerosis	1.44e-05	7.76e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—PIK3CG—atherosclerosis	1.41e-05	7.59e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—NOS3—atherosclerosis	1.4e-05	7.54e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—NFKB1—atherosclerosis	1.34e-05	7.24e-05	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—AKT1—atherosclerosis	1.34e-05	7.2e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—INS—atherosclerosis	1.33e-05	7.19e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MAPK8—atherosclerosis	1.32e-05	7.12e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCL2—atherosclerosis	1.31e-05	7.07e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IGF1—atherosclerosis	1.29e-05	6.95e-05	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—AKT1—atherosclerosis	1.28e-05	6.91e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PTGS2—atherosclerosis	1.28e-05	6.9e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SERPINE1—atherosclerosis	1.23e-05	6.6e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—STAT3—atherosclerosis	1.21e-05	6.51e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—STAT3—atherosclerosis	1.19e-05	6.42e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NOS3—atherosclerosis	1.17e-05	6.3e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MAPK3—atherosclerosis	1.15e-05	6.22e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—MAPK3—atherosclerosis	1.14e-05	6.14e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—TGFB1—atherosclerosis	1.1e-05	5.95e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CXCL8—atherosclerosis	1.04e-05	5.59e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MMP9—atherosclerosis	9.39e-06	5.06e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—NFKB1—atherosclerosis	9.29e-06	5e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAPK8—atherosclerosis	9.13e-06	4.92e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—IL6—atherosclerosis	8.43e-06	4.54e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—VEGFA—atherosclerosis	8.43e-06	4.54e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—STAT3—atherosclerosis	8.35e-06	4.5e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—IL6—atherosclerosis	8.33e-06	4.49e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAPK3—atherosclerosis	7.97e-06	4.3e-05	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—AKT1—atherosclerosis	7.78e-06	4.19e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TGFB1—atherosclerosis	7.74e-06	4.17e-05	CbGpPWpGaD
Porfimer—LDLR—Disease—AKT1—atherosclerosis	7.68e-06	4.14e-05	CbGpPWpGaD
Porfimer—LDLR—Metabolism—AKT1—atherosclerosis	6.43e-06	3.47e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—IL6—atherosclerosis	5.83e-06	3.14e-05	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—AKT1—atherosclerosis	5.38e-06	2.9e-05	CbGpPWpGaD
